InsightsFrenzy.com | Discover Insightful Content

5 things to know about immunotherapy and lung cancer

Advanced lung cancer is difficult to treat since it engulfs other lobes of the lungs and even other organs of the body. Surgical resection does not work in such situations. Doctors usually go with chemotherapy and radiotherapy to treat such patients. However, there are many patients who can’t go through chemotherapy; the side effects are too many. A new treatment for lung cancer is taking shape, and it is called immunotherapy lung cancer.

The aim of this kind of treatment is to strengthen the immune system and release it from the devious cancer cells. This bolsters the immune system to fight the cancer cells.

Immunotherapy lung cancer
Immune checkpoints
The most important aspect of immunotherapy is the immune checkpoint. In this therapy, certain checkpoints in the immune system can be selectively disabled to work to the benefit of the cancer cells.

PD-1 checkpoint
The cancer cells take over the immune checkpoints so that the immune system is not able to target them. There are many such checkpoints in the immune system. The PD-1 checkpoint is one of these. With the help of lung cancer treatment immunotherapy, these checkpoints can be blocked. As the checkpoints are blocked, the immune system regains its insight, identifies the cancer cells and attacks them. The drugs to this effect are administered intravenously and do not necessitate hospitalization.

Only for non-small cell lung cancer
However, it must be said that this therapy is suitable only for non-small cell carcinoma lung cancer patients. It is not yet being used on patients suffering from small cell carcinoma.

Side effects
There are certain side effects of immunotherapy lung cancer, but those are fewer compared to chemotherapy. Most of the side effects involve allergic skin reactions. However, there may be other side effects too, such as inflammation of the lungs or the gut or even abnormalities with the endocrine system.

It does not work for everybody
However, immunotherapy does not work for everybody. It works in about 30% of patients suffering from advanced non-small cell lung cancer. Some patients with a lung tumor respond better to targeted therapy. It has been seen that targeted therapy in some patients with lung cancer can reduce the size of the tumor better than immunotherapy.

Disclaimer:

The content of the articles discussing symptoms, treatments, health conditions, and side effects is solely intended for informational purposes. It is imperative that readers do not interpret the information provided on the website as professional advice. Readers are requested to use their discretion and refrain from treating the suggestions or opinions provided by the writers and editors as medical advice. It is important to seek the help of licensed and expert healthcare professionals when necessary.

Popular Articles

Popular treatment options for metastatic lung cancer

Accounting for 27% of cancer deaths, lung cancer is deadlier than colorectal, breast, and pancreatic cancer. To be safer and increase the chances of a cure, detecting lung cancer in its early stages is important.

Symptoms and Treatment of Stage III Lung Cancer

A major problem with diagnosing lung cancer correctly is that its symptoms can often be mistaken for those of another condition. Signs of cough, back pain, and weight loss are common enough that they aren’t given a second thought to and most people dismiss them.

What Nobody Wants You to Know about Cancer Immunotherapy Treatment

Is this new treatment option as “promising” or “revolutionary” as it is touted to be? Here’s what they do not want you to know about Cancer Immunotherapy treatment. According to the National Cancer Institute , approximately 1.6 million new cases of cancer were diagnosed in 2015, while around 600,000 people are likely to die of the disease this year.

4 Essential Things To Know About Lung Cancer

4 essential things to know about lung cancer Lungs are a vital organ of our respiratory system as they provide purified oxygen from the air we breathe to each cell in our body.

Five Frequently Asked Question About Nsclc And Its Treatments

Five frequently asked question about NSCLC and its treatments There are two main types of lung cancer, non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). The most common type of lung cancer is non-small cell lung cancer (NSCLC) which constitutes about 80 to 85 percent of all cases.

Know More About Cancer Immunotherapy vs Chemotherapy

Immunotherapy tends to give an all-new beginning to the patient and stands head-to-head when compared with standard chemotherapy and the immunotherapy drug nivolumab, Clinical trial research has found that people with squamous non-small cell lung cancer who were treated with nivolumab have lived 3.2 months on an average more than those who were treated with chemotherapy.